nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anatomical site as a parameter in the predictive model of diffuse large B cell lymphoma
|
Kaplan, David |
|
2019 |
76 |
C |
p. 112-113 |
artikel |
2 |
An evolving technology for an evolving disease: A commentary on NGS-based MRD evaluation in B-ALL
|
Fries, Carol |
|
2019 |
76 |
C |
p. 105-106 |
artikel |
3 |
A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients
|
Martínez-Cuadrón, David |
|
2019 |
76 |
C |
p. 1-10 |
artikel |
4 |
Characterization of acute myeloid leukemia with del(9q) – Impact of the genes in the minimally deleted region
|
Naarmann-de Vries, Isabel S. |
|
2019 |
76 |
C |
p. 15-23 |
artikel |
5 |
Clinical impact of chromothriptic complex chromosomal rearrangements in newly diagnosed multiple myeloma
|
Kaur, Gurvinder |
|
2019 |
76 |
C |
p. 58-64 |
artikel |
6 |
Comparison of 18F FDG PET-CT AND CECT in pretreatment staging of adults with Hodgkin’s lymphoma
|
Panebianco, Martina |
|
2019 |
76 |
C |
p. 48-52 |
artikel |
7 |
Compound mutations involving T315I and P-loop mutations are the major components of multiple mutations detected in tyrosine kinase inhibitor resistant chronic myeloid leukemia
|
Kang, Ki-Hoon |
|
2019 |
76 |
C |
p. 87-93 |
artikel |
8 |
Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter?
|
Di Veroli, Ambra |
|
2019 |
76 |
C |
p. 65-69 |
artikel |
9 |
Does hydroxycarbamide therapy really induce leukemic transformation in patients with essential thrombocythemia?
|
Marcellino, B. |
|
2019 |
76 |
C |
p. 94-95 |
artikel |
10 |
Editorial Board
|
|
|
2019 |
76 |
C |
p. ii |
artikel |
11 |
Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience
|
Filì, Carla |
|
2019 |
76 |
C |
p. 33-38 |
artikel |
12 |
Germline CEBPA mutations in Korean patients with acute myeloid leukemia
|
Kim, Hoon Seok |
|
2019 |
76 |
C |
p. 84-86 |
artikel |
13 |
Hepatic and cardiac and iron overload detected by T2* magnetic resonance (MRI) in patients with myelodisplastic syndrome: A cross-sectional study
|
Mantovani, L.F. |
|
2019 |
76 |
C |
p. 53-57 |
artikel |
14 |
Immunohistochemical distinction of ABC and GCB in extranodal DLBCL is not reflected in mutation patterns
|
Hallas, Cora |
|
2019 |
76 |
C |
p. 107-111 |
artikel |
15 |
Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?
|
Brooimans, Rik A. |
|
2019 |
76 |
C |
p. 39-47 |
artikel |
16 |
Impact of NPM1 mutation subtypes on treatment outcome in AML: The Lyon-University Hospital experience
|
Heiblig, Maël |
|
2019 |
76 |
C |
p. 29-32 |
artikel |
17 |
In vitro stability of arsenic trioxide-liposome encapsulates for acute promyelocytic leukemia treatment
|
da Rosa, Francisco Cunha |
|
2019 |
76 |
C |
p. 11-14 |
artikel |
18 |
MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations
|
McReynolds, Lisa J. |
|
2019 |
76 |
C |
p. 70-75 |
artikel |
19 |
Next-generation antigen receptor sequencing of paired diagnosis and relapse samples of B-cell acute lymphoblastic leukemia: Clonal evolution and implications for minimal residual disease target selection
|
Theunissen, Prisca M.J. |
|
2019 |
76 |
C |
p. 98-104 |
artikel |
20 |
Ocular manifestations in acute lymphoblastic leukemia: A five-year cohort study of pediatric patients
|
de Queiroz Mendonca, Cristiano |
|
2019 |
76 |
C |
p. 24-28 |
artikel |
21 |
Rituximab maintenance in elderly patients with follicular lymphoma
|
Casulo, Carla |
|
2019 |
76 |
C |
p. 96-97 |
artikel |
22 |
The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study
|
Vijenthira, Abi |
|
2019 |
76 |
C |
p. 76-81 |
artikel |
23 |
Transplantation for TP53 mutant MDS: Room for improvement
|
Deeren, Dries |
|
2019 |
76 |
C |
p. 82-83 |
artikel |